EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Immunomodulatory Mesoporous Silica Nanoparticles for Inflammatory and Cancer Therapies

Bin Gu, Qin Zhao iD, Yiran Ao

Biomolecules · 2024

DOI: 10.3390/biom14091057 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2024. Verfasst von Bin Gu und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Bio-Medicine Ministry of Education, Hubei Key La…. Hauptthemen laut MEDLINE: Silicon Dioxide, Neoplasms, Nanoparticles, Immunotherapy. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent decades, immunotherapy has been considered a promising treatment approach. The modulatable enhancement or attenuation of the body’s immune response can effectively suppress tumors. However, challenges persist in clinical applications due to the lack of precision in antigen presentation to immune cells, immune escape mechanisms, and immunotherapy-mediated side effects. As a potential delivery system for drugs and immunomodulators, mesoporous silica has attracted extensive attention recently. Mesoporous silica nanoparticles (MSNs) possess high porosity, a large specific surface area, excellent biocompatibility, and facile surface modifiability, making them suitable as multifunctional carriers in immunotherapy. This article summarizes the latest advancements in the application of MSNs as carriers in cancer immunotherapy, aiming to stimulate further exploration of the immunomodulatory mechanisms and the development of immunotherapeutics based on MSNs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Silicon DioxideNeoplasmsNanoparticlesImmunotherapyHumansPorosityAnimalsInflammationDrug CarriersImmunomodulating Agents

Stichwörter der Autor:innen

MSNcancercombined anti-tumor therapyimmunotherapynanoparticles

Substanzen

Silicon DioxideDrug CarriersImmunomodulating Agents

Autor:innen und Institutionen

  • State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Bio-Medicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan Unive…

ORCID-Profile: Qin Zhao

Zitieren

APA

Gu, B., Zhao, Q., & Ao, Y. (2024). Advances in Immunomodulatory Mesoporous Silica Nanoparticles for Inflammatory and Cancer Therapies. Biomolecules. https://doi.org/10.3390/biom14091057

Vancouver

Gu B, Zhao Q, Ao Y. Advances in Immunomodulatory Mesoporous Silica Nanoparticles for Inflammatory and Cancer Therapies. Biomolecules. 2024. doi:10.3390/biom14091057

BibTeX
@article{Gu2024,
  author = {Gu, Bin and Zhao, Qin and Ao, Yiran},
  title = {Advances in Immunomodulatory Mesoporous Silica Nanoparticles for Inflammatory and Cancer Therapies},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14091057}
}
Kostenlos starten →